Insulet Corp (PODD) Stock Price, Quote & News

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system...

Industry: Medical Devices

Sector: Healthcare

Phone: 978 600 7000

Website: www.insulet.com

Address:

100 Nagog Park, Acton, United States

amberajax2point0 Feb. 23 at 3:56 PM

$WGS some beaten up healthcare growth names $PODD, seeing some love today

0 · Reply

SuperGreenToday Feb. 23 at 3:29 PM

$PODD Share Price: $248.26 Contract Selected: Jun 18, 2026 $250 Calls Buy Zone: $16.15 – $19.95 Target Zone: $26.95 – $32.93 Potential Upside: 58% ROI Time to Expiration: 114 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

CEOBuysDisclosures Feb. 23 at 3:20 PM

$PODD CEO purchased 4,300 shares at $239.35 for a total of $1,029,205. McEvoy Ashley now owns 13,920 shares. https://ceo-buys.com

0 · Reply

OfficialStocktwitsUser Feb. 22 at 11:23 PM

$PODD RSI: 40.20, MACD: -8.8909 Vol: 9.23, MA20: 252.44, MA50: 273.97 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

JInvestTrade Feb. 20 at 4:08 AM

$SENS $DXCM $PODD $TNDM $ABT https://www.linkedin.com/posts/eversense-cgm_eversense365-eversensecgm-diabetes-activity-7430271018340024322-zPai?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=copy_link

0 · Reply

passiontrader1 Feb. 19 at 5:12 PM

$PODD short squeeze starting now$META $ TSLA

0 · Reply

healthcareguru Feb. 19 at 3:28 PM

$PODD this underperformance has gotten stupid…starting to build large.

0 · Reply

ZacksResearch Feb. 19 at 1:30 PM

$PODD shares spike 4.8% after strong Q4 results! 🚀 🔹 EPS of $1.55 beat estimates by 4.87% 🔹 Q4 revenues surged 31.2% YoY, with 29% growth at constant exchange rate topping guidance 🔹 Record new Omnipod customer starts But with a Zacks Rank #4 (Sell), what’s next for Insulet? Full insights here 👉 https://www.zacks.com/stock/news/2871842/podd-stock-up-on-q4-earnings-revenue-beat-margins-rise?cid=sm-stocktwits-2-2871842-body-34152&ADID=SYND_STOCKTWITS_TWEET_2_2871842_BODY_34152

0 · Reply

ZacksResearch Feb. 19 at 12:30 PM

$PODD just delivered the kind of quarter bulls love 🚀 Q4 earnings and revenue both beat expectations, and margins moved higher — that’s a powerful combo. When a company is growing the top line and expanding profitability, the market pays attention. Momentum building here. Get the full breakdown 👉 https://www.zacks.com/stock/news/2871842/podd-stock-up-on-q4-earnings-revenue-beat-margins-rise?cid=sm-stocktwits-2-2871842-teaser-34143&ADID=SYND_STOCKTWITS_TWEET_2_2871842_TEASER_34143

0 · Reply

passiontrader1 Feb. 18 at 7:33 PM

$PODD anyone wants to make a quick $10/share -golden opportunity! This is a 270 stock tomorrow $TSLA, $MSFT, $AMZN

0 · Reply

Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations

Feb 18, 2026, 4:54 PM EST - 7 days ago

Insulet Corporation (PODD) Q4 2025 Earnings Call Transcript

Feb 18, 2026, 1:57 PM EST - 7 days ago

Diabetes-Focused Insulet Forecasts Strong 2026 Growth, Stock Soars

Feb 18, 2026, 7:55 AM EST - 8 days ago

Insulet beats quarterly estimates on strong demand for wearable insulin pumps

Feb 18, 2026, 7:00 AM EST - 8 days ago

Insulet Reports Fourth Quarter and Full Year 2025 Results

Feb 5, 2026, 7:00 AM EST - 21 days ago

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

Jan 19, 2026, 12:41 PM EST - 5 weeks ago

Is PODD A Better Bet Than ISRG Stock?

ISRG

Jan 13, 2026, 4:05 PM EST - 6 weeks ago

Insulet Corporation (PODD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 9, 2026, 6:00 AM EST - 6 weeks ago

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

Jan 6, 2026, 7:00 AM EST - 7 weeks ago

Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health

Dec 16, 2025, 7:00 AM EST - 2 months ago

Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference

Dec 15, 2025, 7:00 AM EST - 2 months ago

Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future

Dec 11, 2025, 10:37 AM EST - 2 months ago

Eight stock picks to play one of the healthiest corners of the market

ALNY ASND INSM MASI NTRA UNH WGS

Dec 4, 2025, 7:00 AM EST - 3 months ago

Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience

Nov 26, 2025, 8:00 AM EST - 3 months ago

Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off

SEDG

Nov 20, 2025, 8:13 PM EST - 3 months ago

Insulet Corporation (PODD) Analyst/Investor Day Transcript

Nov 20, 2025, 12:30 PM EST - 3 months ago

Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day

Nov 12, 2025, 2:15 PM EST - 3 months ago

PODD Vs. Intuitive Surgical: This Underdog Might Just Win

ISRG

Nov 6, 2025, 12:46 PM EST - 3 months ago

Insulet Corporation (PODD) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 7:29 AM EST - 4 months ago

Insulet tops quarterly estimates on demand for wearable insulin pumps

Nov 6, 2025, 6:30 AM EST - 4 months ago

Insulet Reports Third Quarter 2025 Results

Nov 4, 2025, 1:20 PM EST - 4 months ago

Final Trades: Insulet Corp, Uber and Apollo Global

APO UBER

Oct 30, 2025, 4:00 AM EDT - 4 months ago

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

Oct 23, 2025, 11:29 AM EDT - 4 months ago

10 stocks primed for growth in the S&P 500's cheapest sectors

BX AJG APO BRO DXCM FITB HOOD

Oct 23, 2025, 7:00 AM EDT - 4 months ago

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

Oct 10, 2025, 7:00 AM EDT - 4 months ago

Insulet to Host Investor Day on November 20, 2025

Sep 22, 2025, 10:19 AM EDT - 5 months ago

These 15 stocks have beaten the S&P 500 this year — while getting cheaper in the process

ADI BA CCL COIN DASH NUE NVDA

Sep 18, 2025, 7:00 AM EDT - 5 months ago

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

Sep 16, 2025, 7:25 AM EDT - 5 months ago

Medical device maker Insulet names industry veteran Flavia Pease as CFO

Sep 16, 2025, 7:00 AM EDT - 5 months ago

Insulet Announces CFO Transition

Sep 9, 2025, 2:31 PM EDT - 6 months ago

Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 4, 2025, 6:33 PM EDT - 6 months ago

Insulet Corporation (PODD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Aug 25, 2025, 5:00 PM EDT - 6 months ago

Insulet Elevates Eric Benjamin to Chief Operating Officer

Aug 19, 2025, 1:20 PM EDT - 6 months ago

Final Trades: Rocket Companies, Cisco Systems, Insulet Corp and the IGV

CSCO RKT IGV

Aug 19, 2025, 6:00 AM EDT - 6 months ago

Insulet to Participate in Upcoming Investor Conferences

Aug 15, 2025, 8:52 AM EDT - 6 months ago

20 stocks in the S&P 500 that are high achievers this earnings season

ANET APH COIN CTRA EQT EXE FICO

Aug 13, 2025, 11:49 PM EDT - 7 months ago

Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold

Aug 7, 2025, 1:08 PM EDT - 7 months ago

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5

Aug 7, 2025, 11:14 AM EDT - 7 months ago

Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 8:39 AM EDT - 7 months ago

Insulet beats second-quarter profit estimates on strong demand for insulin pumps

Aug 7, 2025, 7:00 AM EDT - 7 months ago

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

Jul 31, 2025, 9:52 AM EDT - 7 months ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

BSX CAH DXCM EW ISRG LLY SYK

Jul 21, 2025, 10:27 AM EDT - 7 months ago

15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

CMG COF DXCM FSLR INTU LLY MA

Jul 8, 2025, 6:00 AM EDT - 8 months ago

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

Jun 19, 2025, 6:00 AM EDT - 9 months ago

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

Jun 10, 2025, 10:53 AM EDT - 9 months ago

20 stocks bucking bad trends on Wall Street — what might be next for them?

AMT ANET AVGO BSX TRMB BAC C

Jun 10, 2025, 8:30 AM EDT - 9 months ago

Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

Jun 9, 2025, 9:28 AM EDT - 9 months ago

20 stocks of companies that have improved profit margins and are expected to grow quickly

AMD AVGO CSGP DASH ENPH FICO FTNT

May 23, 2025, 6:01 AM EDT - 9 months ago

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 14, 2025, 7:20 AM EDT - 10 months ago

Outlier Money Flows Lift Insulet

amberajax2point0 Feb. 23 at 3:56 PM

$WGS some beaten up healthcare growth names $PODD, seeing some love today

0 · Reply

SuperGreenToday Feb. 23 at 3:29 PM

0 · Reply

CEOBuysDisclosures Feb. 23 at 3:20 PM

$PODD CEO purchased 4,300 shares at $239.35 for a total of $1,029,205. McEvoy Ashley now owns 13,920 shares. https://ceo-buys.com

0 · Reply

OfficialStocktwitsUser Feb. 22 at 11:23 PM

0 · Reply

JInvestTrade Feb. 20 at 4:08 AM

0 · Reply

passiontrader1 Feb. 19 at 5:12 PM

$PODD short squeeze starting now$META $ TSLA

0 · Reply

healthcareguru Feb. 19 at 3:28 PM

$PODD this underperformance has gotten stupid…starting to build large.

0 · Reply

ZacksResearch Feb. 19 at 1:30 PM

0 · Reply

ZacksResearch Feb. 19 at 12:30 PM

0 · Reply

passiontrader1 Feb. 18 at 7:33 PM

$PODD anyone wants to make a quick $10/share -golden opportunity! This is a 270 stock tomorrow $TSLA, $MSFT, $AMZN

0 · Reply

passiontrader1 Feb. 18 at 7:06 PM

$PODD bull run begins now!!!! $TSLA $META

0 · Reply

SunshineTiger Feb. 18 at 5:00 PM

$PODD 2 of 2 Insulet corporation has chosen to live in the past just like they will eventually be, Omnipod is a stagnant swamp, they are the 1-trick pony of life. Insulet are not true creators like us, true creators and inovators move fast create daily as desired easily. Insulet Corporation is the rock in the river, it creates interest as we flow by but I am not a rock I am human and for all those who suffer with these diseases that we or our loved ones have remember this "we are the river" and our perspective is greater than any rock or Everest. I encourage challenge to any giants like this because only then can "steel sharpen steel", without you the challenger Omnipod and Insulet are suffered to stagnate, obeying investor wants over the lives they effect, living in fear of a failure by avoiding creative advancements since they ultimately no longer carry the "spark" that makes life memorable or beautiful.

1 · Reply

SunshineTiger Feb. 18 at 4:59 PM

$PODD Time to bring the truth on this, bear in mind as I write this review at 4am. I've used omnipod since their very beginning, when it works its fine. The item has a place in health care, not advanced health care but average healthcare. This is the problem with a business model that is stuck in "we made a thing mode". They are not a diabetics best friend, What have they done to advance health care as a giant in the last 20yrs? Insulet Corporation is like any other corpo hoping to survive while clinging to their "Precious" and does this help future you and me? Does this advance healthcare to the next level relative to the world moving so fast with tech, for diabetics and others who use this delivery patch on this planet? This is my perspective in a multipolar world Insulet Corporation brings nothing new to market, fights off challengers with patents litigation defense, all so they can milk you and I like a cow.

0 · Reply

passiontrader1 Feb. 18 at 4:47 PM

$PODD Time for short squeeze!!!!!!!!! $META $TSLA

0 · Reply

passiontrader1 Feb. 18 at 4:46 PM

$PODD RUNNING BACK TO 267 EOD!!

0 · Reply

BillionerOfKing Feb. 18 at 4:00 PM

$PODD Current Stock Price: $266.80 Contracts to trade: $270.0 PODD Feb 20 2026 Call Entry: $3.50 Exit: $4.55 ROI: 30% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

TheDizPlinTrader Feb. 18 at 1:55 PM

$PODD 💉 1 Hour Levels Price: $265.40 Support: $257.40 Resistance: $274.90 👉 Tap follow to keep these 1-hour levels on your feed.

0 · Reply

DonCorleone77 Feb. 18 at 1:09 PM

$PODD Insulet sees FY26 adjusted EPS up at least 25% Sees FY26 revenue up 20%-22%.

0 · Reply

DonCorleone77 Feb. 18 at 1:09 PM

$PODD Insulet sees Q1 revenue up 25%-27% Sees Q1 Omnipod products revenue up 28%-30%.

0 · Reply

DonCorleone77 Feb. 18 at 1:08 PM

$PODD Insulet reports Q4 adjusted EPS $1.55, consensus $1.46 Reports Q4 revenue $783.8M, consensus $768.73M. "We ended the year with another excellent quarter, demonstrating the power of our business model, the strength of our technology, and the disciplined execution of our team," said Ashley McEvoy, President and CEO. "Our performance shows that Insulet continues to lead with innovation, scale, and customer trust - and that our competitive position has never been stronger. As we move into 2026, we are confident in our ability to grow the global AID market, expand adoption across type 1 and type 2 diabetes, and deliver on the strategic and financial commitments we have laid out. Insulet has the talent, the technology, and the momentum to lead this category for the long term."

0 · Reply

jheerdink Feb. 18 at 1:00 PM

$MODD https://vistapglobal.com/year-of-the-horsepower-insulets-earnings-sprint-and-modular-medicals-quiet-canter-modd-podd/ $PODD

0 · Reply

StocktwitsEarnings Feb. 18 at 12:11 PM

$PODD Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $1.44 • Reported revenue of $783.8M up 31.18% YoY • For fiscal year 2026, Insulet projects total revenue growth of 20% to 22% in constant currency, with adjusted operating margin expanding by approximately 100 basis points year-over-year, and adjusted EPS growth exceeding 25%.

0 · Reply

Market Cap	17.26B
Revenue (ttm)	2.71B
Net Income (ttm)	247.10M
EPS (ttm)	N/A
PE Ratio	50.08
Forward PE	40.33
Profit Margin	9.12%
Debt to Equity Ratio	0.63

Volume	879,900
Avg Vol	926,022
Day's Range	N/A - N/A
Shares Out	70.40M
Stochastic %K	29%
Beta	1.41
Analysts	Strong Sell
Price Target	$356.08